Quest closes purchase of Athena

04/4/2011 | Mass High Tech (Boston)

Quest Diagnostics has concluded its acquisition of Athena Diagnostics, a former Thermo Fisher Scientific division, for about $740 million. Quest said Athena would continue to operate as an independent business that focuses on the development of diagnostic tests for Alzheimer's disease and other neurological conditions.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care